Early obesity linked to dangerous blood clots in men
In a new study, researchers found that Men with a history of obesity in their late teens are, in adult life, more at risk...
This new drug shows promise in battle against COVID-19
In several new studies, researchers found that a new anti-viral drug has had positive results in laboratory tests against COVID-19.
They drug is developed by...
COVID-19 linked to higher stroke risk in some patients, new study shows
In a new study, researchers found that COVID-19 might raise stroke risk in young and middle-aged adults, with virus-linked blood clots causing severe damage...
This diabetes drug may help prevent serious kidney problems
In a new study, researchers found that the use of sodium-glucose cotransporter 2 (SGLT2) inhibitors to treat type 2 diabetes may help to lower...
Millions of US workers at risk of COVID-19 infections on the job
In a new study, researchers found that 14.4 million workers face exposure to infection once a week and 26.7 million at least once a...
How could COVID-19 and the body’s immune response affect the brain?
Picower Institute researchers are embarking on experiments to learn the mechanisms by which coronavirus might affect mental health. MIT news
Written by David Orenstein, Picower...
This blood test may help detect cancer before symptoms appear
In a new study, researchers have developed a blood test that could help detect many types of cancer in people with no history or...
This cancer-fighting compound could fight diabetes and obesity
Obesity affects 40% of adults in the United States, resulting in health conditions that include heart disease, high blood pressure, type 2 diabetes, and...
Scientists find low-cost therapy that could effectively treat high blood pressure
Uncontrolled high blood pressure, a major risk factor for heart and kidney diseases, is a leading cause of death globally.
In rural parts of low-...
Why does COVID-19 affect old people more than young people?
As we age, our lung tissue becomes stiffer—and this is a phenomenon that SARS-CoV-2 may be exploiting. Caroline Uhler and G. V. Shivashankar outline...